☆ 4.6 Article

A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19-A Propensity Score-Matched Control Analysis

MICROORGANISMS (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Hematology

Convalescent plasma therapy in patients with COVID-19

Fevzi Altuntas et al.

Summary: This study indicated that convalescent plasma (CP) therapy can reduce the duration in the intensive care unit, rates of mechanical ventilation support and vasopressor support in severe and critically ill patients with COVID-19, as well as decrease the case fatality rate. Early administration of CP after COVID-19 diagnosis is associated with a better outcome in terms of mechanical ventilation support.

TRANSFUSION AND APHERESIS SCIENCE (2021)

添加到收藏夹

Article Hematology

Early mortality benefit with COVID-19 convalescent plasma: a matched control study

Aarthi G. Shenoy et al.

Summary: The study demonstrated that patients with COVID-19 who received CCP had a decreased risk of death at 7 and 14 days, but not 28 days after transfusion, compared to matched controls.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

添加到收藏夹

Article Immunology

Efficacy and safety of convalescent plasma therapy in severe COVID-19 patients with acute respiratory distress syndrome *

Abolghasem Allahyari et al.

Summary: The study evaluated the safety and efficacy of convalescent plasma therapy for severe COVID-19 cases with ARDS, showing that early administration of convalescent plasma can contribute to the treatment of severe COVID-19 patients with mild or moderate ARDS by reducing mortality rate, disease severity, ICU stay, and need for intubation while increasing oxygenation levels.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults

R. Libster et al.

Summary: A randomized, double-blind, placebo-controlled trial of convalescent plasma with high IgG titers against SARS-CoV-2 in older adult patients within 72 hours after the onset of mild Covid-19 symptoms found that early administration of high-titer convalescent plasma reduced the progression of Covid-19 in mildly ill infected older adults.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19

M. J. Joyner et al.

Summary: This study found that higher anti-SARS-CoV-2 IgG antibody levels in convalescent plasma were associated with a lower risk of death among patients hospitalized with Covid-19 who were not receiving mechanical ventilation. The association between antibody levels and mortality risk was moderated by mechanical ventilation status, with no significant effect seen in patients who had already received ventilation.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia

V. A. Simonovich et al.

Summary: There were no significant differences observed in clinical status or overall mortality between patients treated with convalescent plasma and those who received placebo in the treatment of severe Covid-19 pneumonia. The study results indicate that both groups had similar clinical outcomes and mortality rates after 30 days.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Immunology

Matched Cohort Study of Convalescent COVID-19 Plasma Treatment in Severely or Life Threateningly Ill COVID-19 Patients

Marc Klapholz et al.

Summary: This study evaluated the safety and efficacy of convalescent coronavirus disease 2019 (COVID-19) plasma (CCP) in severely or life-threateningly ill patients, showing that CCP transfusion was safe and had a nonsignificant association with study outcomes. Further randomized and larger trials are needed to determine the appropriate timing and dosing of CCP in COVID-19.

OPEN FORUM INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Hematology

A matched cohort study of convalescent plasma therapy for COVID-19

Oleg V. Sostin et al.

Summary: In this study, the authors evaluated the treatment efficacy of convalescent plasma in patients with COVID-19 and found no evidence that convalescent plasma reduced in-hospital mortality or shortened hospital length of stay.

JOURNAL OF CLINICAL APHERESIS (2021)

添加到收藏夹

Article Medicine, General & Internal

Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial

Maria Elvira Balcells et al.

Summary: The study did not find evidence of benefit in mortality, length of hospitalization, or mechanical ventilation requirement by immediate addition of CP therapy in the early stages of COVID-19 compared to its use only in case of patient deterioration.

PLOS MEDICINE (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma

Michele L. Donato et al.

Summary: The study demonstrated that therapeutic use of CCP was safe and effective in transferring antibodies to COVID-19 patients, while maintaining their endogenous immune response.

JCI INSIGHT (2021)

添加到收藏夹

Article Medicine, General & Internal

Effect of Convalescent Plasma in Critically Ill Patients With COVID-19: An Observational Study

Pedro Kurtz et al.

Summary: This study found that convalescent plasma did not lead to clinical improvement or increased 28-day survival in critically ill patients with COVID-19. Biomarker assessment showed reduced inflammatory activity and increased lymphocyte count in convalescent plasma recipients.

FRONTIERS IN MEDICINE (2021)

添加到收藏夹

Article Hematology

Effectiveness of convalescent plasma in Indian patients with COVID-19

Sandeep Budhiraja et al.

Summary: This study found that the use of convalescent plasma (CP) in hospitalized COVID-19 patients can lower mortality rates in ICU patients, especially for those over 60 years old, females, patients with comorbidities, and those requiring some form of ventilation.

BLOOD CELLS MOLECULES AND DISEASES (2021)

添加到收藏夹

Article Infectious Diseases

Convalescent plasma treatment is associated with lower mortality and better outcomes in high-risk COVID-19 patients - propensity-score matched case-control study

Adam Tworek et al.

Summary: This study confirmed a significantly lower mortality rate in patients treated with convalescent plasma, with no significant differences in ventilator time, ICU stay, and overall hospitalization time between the two groups. Age, cardiac insufficiency, active cancer, ventilator requirement, and length of hospitalization significantly increased the risk of death in both groups.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Medicine, General & Internal

Safety and Efficacy of Convalescent Plasma for Severe COVID-19: Interim Report of a Multicenter Phase II Study from Saudi Arabia

Nawal AlShehry et al.

Summary: The interim findings of a national study investigating convalescent plasma as a treatment strategy for severe COVID-19 showed that CP containing detectable antibodies is a safe and potentially effective option, with a possible decrease in mortality rates observed in patients who received the treatment.

SAUDI JOURNAL OF MEDICINE & MEDICAL SCIENCES (2021)

添加到收藏夹

Article Rheumatology

Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial

Maria Isabel Lopes et al.

Summary: Colchicine showed benefits in the treatment of COVID-19 patients by reducing the need for supplemental oxygen and length of hospitalisation. It did not necessarily reduce mortality, but was safe and well tolerated with the potential side effect of diarrhea.

RMD OPEN (2021)

添加到收藏夹

Review Medicine, Research & Experimental

The 2020 race towards SARS-CoV-2 specific vaccines

Tomasz M. Karpinski et al.

Summary: The global outbreak of COVID-19 has emphasized the urgent need for effective vaccines and treatments. Advances in biotechnology and genetic engineering have provided progress in understanding the virus, with the development of vaccines being a key focus. Challenges in vaccine development and distribution, as well as the importance of safety and long-term effectiveness, have also been highlighted.

THERANOSTICS (2021)

添加到收藏夹

Editorial Material Medicine, General & Internal

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Zunyou Wu et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Article Multidisciplinary Sciences

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Peng Zhou et al.

NATURE (2020)

添加到收藏夹

Review Immunology

Convalescent plasma in Covid-19: Possible mechanisms of action

Manuel Rojas et al.

AUTOIMMUNITY REVIEWS (2020)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems

Acute pulmonary embolism and COVID-19 pneumonia: a random association?

Gian Battista Danzi et al.

EUROPEAN HEART JOURNAL (2020)

添加到收藏夹

Article Medicine, General & Internal

Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma

Chenguang Shen et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Letter Medicine, General & Internal

Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State

Matt Arentz et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Article Medicine, General & Internal

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

Safiya Richardson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Effectiveness of convalescent plasma therapy in severe COVID-19 patients

Kai Duan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

添加到收藏夹

Article Virology

Treatment with convalescent plasma for COVID-19 patients in Wuhan, China

Mingxiang Ye et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

Tao Chen et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

添加到收藏夹

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Letter Medicine, General & Internal

Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

Yan Zhang et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Pathology

Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality

Eric Salazar et al.

AMERICAN JOURNAL OF PATHOLOGY (2020)

添加到收藏夹

Article Hematology

Mortality reduction in 46 patients with severe COVID-19 treated with hyperimmune plasma A proof-of-concept, single-arm, multicenter trial .

Cesare Perotti et al.

HAEMATOLOGICA (2020)

添加到收藏夹

Article Medicine, General & Internal

Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 A Randomized Clinical Trial

Ling Li et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Article Immunology

Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses

Fabian Schmidt et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients

Michael J. Joyner et al.

MAYO CLINIC PROCEEDINGS (2020)

添加到收藏夹

Article Hematology

Lessons learned from early compassionate use of convalescent plasma on critically ill patients withCovid-19

Miao Liu et al.

TRANSFUSION (2020)

添加到收藏夹

Article Hematology

Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study

Hassan Abolghasemi et al.

TRANSFUSION AND APHERESIS SCIENCE (2020)

添加到收藏夹

Letter Hematology

Convalescent plasma from COVID 19 patients enhances intensive care unit survival rate. A preliminary report

Italo Cantore et al.

TRANSFUSION AND APHERESIS SCIENCE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study

Sean T. H. Liu et al.

NATURE MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)

Anup Agarwal et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

添加到收藏夹

Article Microbiology

Anti-SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study

Evangelos Terpos et al.

MICROORGANISMS (2020)

添加到收藏夹

Review Hematology

The Emerging Role of Convalescent Plasma in the Treatment of COVID-19

Theodora Psaltopoulou et al.

HEMASPHERE (2020)

添加到收藏夹

Review Medicine, Research & Experimental

SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy

Prasun K. Datta et al.

THERANOSTICS (2020)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems

Acute pulmonary embolism and COVID-19 pneumonia: a random association?

Gian Battista Danzi et al.

EUROPEAN HEART JOURNAL (2020)

添加到收藏夹

Review Microbiology

Viral-Induced Enhanced Disease Illness

Maria K. Smatti et al.

FRONTIERS IN MICROBIOLOGY (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Antibody-dependent enhancement of severe dengue disease in humans

Leah C. Katzelnick et al.

SCIENCE (2017)

添加到收藏夹

Review Immunology

Fc receptors in antibody-dependent enhancement of viral infections

Adam Taylor et al.

IMMUNOLOGICAL REVIEWS (2015)

添加到收藏夹

Article Critical Care Medicine

The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation

Alan E. Jones et al.

CRITICAL CARE MEDICINE (2009)

添加到收藏夹

Article Infectious Diseases

Use of convalescent plasma therapy in SARS patients in Hong Kong

Y Cheng et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)

添加到收藏夹

Review Infectious Diseases

Treatment of severe acute respiratory syndrome

ST Lai

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)

添加到收藏夹

Article Infectious Diseases

Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients

YOY Soo et al.

CLINICAL MICROBIOLOGY AND INFECTION (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.